Chiome Bioscience News

Chiome Bioscience: Notice Concerning Mass Exercise of the 21st Stock Acquisition Rights (with Exercise Price Amendment Clauses)

07:50

Chiome Bioscience: [Revised] Chiome Announces Exclusive Licensing Agreement for Anti-CX3CR1 Antibody

Nov 20 17:00

Chiome Bioscience: Chiome Announces Exclusive Licensing Agreement for Anti-CX3CR1 Antibody

Nov 20 14:30

Chiome Bioscience: Announcement of the conclusion of an exclusive license agreement for our anti-CX3CR1 antibody

Nov 20 14:30

Chiome Bioscience: Confirmatory letter.

Nov 15 14:48

Chiome Bioscience: Corrected Financial Report - 20th Term (2023/01/01 - 2023/12/31)

Nov 15 14:45

Chiome Bioscience: change report

Nov 14 09:23

Chiome Bioscience: Non-Consolidated Financial Results (Japanese GAAP) for the Nine Months Ended September 30, 2024

Nov 12 15:00

Chiome Bioscience: Financial results supplementary materials 3rd quarter of the fiscal year ending 2024/12

Nov 12 15:00

Chiome Bioscience: Notice regarding the recording of non-operating expenses and revisions to earnings forecasts

Nov 12 15:00

Chiome Bioscience: Supplementary Information for Financial Results Q3 FY12/24

Nov 12 15:00

Chiome Bioscience: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 12 15:00

Chiome Bioscience: Notice of presentation of research results using our antibodies at the 3rd Annual Meeting of the Japanese Antibody Society

Nov 5 12:00

Chiome Bioscience: Notice regarding the monthly exercise status of the 21st Stock Acquisition Rights (with exercise price amendment clause)

Nov 1 11:00

Chiome Bioscience: Announcement of research results using our antibodies at the World Flu Day 2024 Symposium

Oct 31 13:30

Chiome Bioscience: Notice Concerning Mass Exercise of the 21st Stock Acquisition Rights (with Exercise Price Amendment Clauses)

Oct 30 07:50

Chiome Bioscience: Notice of addition of melanoma part for cancer treatment antibody CBA-1205

Oct 29 09:00

Chiome Bioscience: Change Report

Oct 28 14:35

Chiome Bioscience: Announcement of research results related to the ADLib system at Antimide Engineering & Therapeutics Asia 2024

Oct 16 09:30

Chiome Bioscience: Announcement of research results using our antibodies at the 39th American Society for Cancer Immunotherapy

Oct 7 09:20